BioCardia, Inc. (BCDAD) financial statements (2021 and earlier)

Company profile

Business Address 125 SHOREWAY ROAD
SAN CARLOS, CA 94070
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments216513211414
Cash and cash equivalents216513211414
Receivables10000  
Inventory, net of allowances, customer advances and progress billings 0000  
Inventory 0000  
Prepaid expense  000  
Other undisclosed current assets01     
Total current assets:236613221414
Noncurrent Assets
Operating lease, right-of-use asset11
Property, plant and equipment00000  
Other noncurrent assets00000  
Total noncurrent assets:11000  
Other undisclosed assets     00
TOTAL ASSETS:238614221414
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1121100
Accounts payable11111  
Accrued liabilities00011  
Other undisclosed accounts payable and accrued liabilities     00
Deferred revenue10
Deferred revenue and credits00  
Customer advances and deposits0   
Contract with customer, liability0
Other undisclosed current liabilities33110  
Total current liabilities:4432100
Noncurrent Liabilities
Long-term debt and lease obligation 1     
Operating lease, liability 1
Liabilities, other than long-term debt 1000  
Deferred revenue and credits00  
Deferred revenue 1
Deferred rent credit  0
Total noncurrent liabilities: 1000  
Total liabilities:4532200
Stockholders' equity
Stockholders' equity attributable to parent192411211414
Common stock0000000
Additional paid in capital1351039084802626
Accumulated deficit(116)(101)(86)(72)(60)(12)(12)
Total stockholders' equity:192411211414
TOTAL LIABILITIES AND EQUITY:238614221414

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues0110110
Revenue, net0110
Other operating income000    
Cost of revenue
(Cost of Goods and Services Sold)
(0)(0)(1)(1)(1)  
Gross profit:000(0)(0)10
Operating expenses(16)(15)(14)(12)(7)(0)(0)
Other operating income, net      0
Other undisclosed operating loss      (0)
Operating income (loss):(16)(14)(14)(12)(8)00
Nonoperating income (expense)1(0)00(3)  
Interest and debt expense(0)(1)  (2)  
Income (loss) from continuing operations before equity method investments, income taxes:(15)(15)(14)(12)(12)00
Other undisclosed income from continuing operations before income taxes     00
Net income (loss):(15)(15)(14)(12)(12)00
Other undisclosed net income attributable to parent01  2  
Net income (loss) available to common stockholders, diluted:(15)(15)(14)(12)(10)00

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss):(15)(15)(14)(12)(12)00
Comprehensive income (loss), net of tax, attributable to parent:(15)(15)(14)(12)(12)00

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: